Inventor · disambiguated record
Claude Geoffrey Davis
Also filed as: DAVIS CLAUDE · DAVIS CLAUDE G · DAVIS CLAUDE GEOFFREY
16 granted patents·9 pending applications·1,594 citations·filing 1991–2024
95Inventor score
Files withANGIOCRINE BIOSCIENCE INC8ABGENIX INC5DAVIS CLAUDE GEOFFREY3DAVIS CLAUDE2AMGEN FREMONT INC1
Top patents by PatentIndex Score
25 records- 0198US5916771AProduction of a multimeric protein by cell fusion methodABGENIX INC·Filed 1996·Granted Jun 29, 1999·1k cites·11 claims
- 0297US6029600AClean hands assuredFiled 1998·Granted Feb 29, 2000·138 cites·13 claims
- 0395US6420140B1Production of multimeric protein by cell fusion methodABGENIX INC·Filed 2001·Granted Jul 16, 2002·122 cites·27 claims
- 0495US6207418B1Production of a multimeric protein by cell fusion methodABGENIX INC·Filed 1999·Granted Mar 27, 2001·86 cites·11 claims
- 0589US8470314B2Modified toxinsDAVIS CLAUDE GEOFFREY·Filed 2008·Granted Jun 25, 2013·12 cites·24 claims
- 0685US6677138B2Production of a multimeric protein by cell fusion methodABGENIX INC·Filed 2001·Granted Jan 13, 2004·8 cites·8 claims
- 0783US9976698B1Multi-angle television wall mountDAVIS CLAUDE·Filed 2016·Granted May 22, 2018·9 cites·1 claims
- 0883US5258289AMethod for the selecting of genes encoding catalytic antibodiesDAVIS CLAUDE G·Filed 1991·Granted Nov 2, 1993·98 cites·8 claims
- 0982US10059750B2Modified toxinsANGELICA THERAPEUTICS INC·Filed 2014·Granted Aug 28, 2018·12 cites·8 claims
- 1082US7429380B2Production of a multimeric protein by cell fusion methodAMGEN FREMONT INC·Filed 2003·Granted Sep 30, 2008·5 cites·13 claims
- 1179US8067011B2Compositions and methods for treating B-cell malignanciesDAVIS CLAUDE GEOFFREY·Filed 2007·Granted Nov 29, 2011·7 cites·28 claims
- 1278US8252897B2Modified toxinsDAVIS CLAUDE GEOFFREY·Filed 2008·Granted Aug 28, 2012·5 cites·18 claims
- 1377US10961509B2Engineered endothelial cells expressing an ETS transcription factorANGIOCRINE BIOSCIENCE INC·Filed 2016·Granted Mar 30, 2021·2 cites·12 claims
- 1471US2025115931A1Enhanced gene delivery methodsANGIOCRINE BIOSCIENCE INC·Filed 2024·Application pending·0 cites
- 1568US5602021AMethod for generating proteolytic enzymes specific against a selected peptide sequenceCATALYTIC ANTIBODIES INC·Filed 1994·Granted Feb 11, 1997·46 cites·14 claims
- 1666US2023414671A1Methods and compositions for stem cell transplantationANGIOCRINE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1763US10947500B2Neural cells expressing adenovirus E4ORF1, and methods of making and using the sameANGIOCRINE BIOSCIENCE INC·Filed 2015·Granted Mar 16, 2021·1 cites·36 claims
- 1861USD815624SMulti-angle television wall-mountDAVIS CLAUDE·Filed 2016·Granted Apr 17, 2018·9 cites·1 claims
- 1960US2003022291A1Production of a multimeric protein by cell fusion methodFiled 2002·Application pending·0 cites
- 2057US2022204924A1Engineered endothelial cells expressing an ets transcription factorANGIOCRINE BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 2156US2003092125A1Epitope-driven human antibody production and gene expression profilingABGENIX INC·Filed 2002·Application pending·0 cites
- 2245US2019127760A1Enhanced gene delivery methodsANGIOCRINE BIOSCIENCE INC·Filed 2017·Application pending·0 cites
- 2337US2018214488A1Methods and compositions for stem cell transplantationANGIOCRINE BIOSCIENCE INC·Filed 2016·Application pending·0 cites
- 2437US2017360988A1Biocompatible implants comprising engineered endothelial cellsANGIOCRINE BIOSCIENCE INC·Filed 2015·Application pending·0 cites
- 2530US2002029391A1Epitope-driven human antibody production and gene expression profilingFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claude Geoffrey Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →